… lymphocyte chimerism [24]. We sought to examine the effect of mixed T lymphocyte chimerism
… the potential utility of T lymphocyte chimerism analysis between post-transplantation day +…

… In summary, the recommendations are that chimerism … marrow; that lineage-specific chimerism
should be the assay of … human thoracic duct lymphocytes suppresses T lymphocytes. It …

… lymphocyte infusion (DLI) than those with hematological evidence of disease. In those with
acute leukemia and myelodysplastic syndromes (… Therefore, chimerism analysis, using PCR …

… for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Therapeutic options
for … , either alone or in combination with donor lymphocyte infusions; or a second alloSCT. …

… patients with progressively declining donor CD3 chimerism or relapsed disease post-TCD …
requirement for pDLI by repeat chimerism assessment. The chimerism response to pDLI was …

… Lymphocytes are probably not involved in the clonal hematopoiesis in MDS (24), but … in a
chimerism to encourage a graft-versus-MDS/AML effect. This approach is still investigational. …

CD34+ lineage specific donor cell chimerism for the diagnosis and treatment of impending
relapse of AML or myelodysplastic syndrome after allo-SCT | Bone Marrow Transplantation …

… 9 and acute lymphocytic leukemia (ALL), 10 and it is likely to play a similar role in MDS. …
facilitate donor engraftment and establish complete donor chimerism. Kröger et al 21 reported …

… cell subpopulations when routine serial analysis of chimerism had revealed increasing MC
in the … Interestingly, freshly obtained donor lymphocytes showed alloreactivity towards these …

… ment for patients with myelodysplastic syndrome (MDS)… chimerism analysis at relapse
showed hematopoiesis to be entirely of donor origin confirming donor cell MDS. Donor lymphocyte …